ライフサイエンスコーパス: endarterectomy

1 arotid artery stenting, 1105 who had carotid endarterectomy).

2 thy controls and patients undergoing carotid endarterectomy.

3 rs for 26 +/- 8 months before undergoing the endarterectomy.

4 d 30 nondiabetic patients undergoing carotid endarterectomy.

5 stenosis most likely to benefit from carotid endarterectomy.

6 sonance imaging, 46.9% (n=15) before carotid endarterectomy.

7 ues removed from patients undergoing carotid endarterectomy.

8 swelling in his left neck after left carotid endarterectomy.

9 r carotid artery stenting than after carotid endarterectomy.

10 atherosclerotic plaques obtained at carotid endarterectomy.

11 with carotid artery stenting versus carotid endarterectomy.

12 o receive carotid artery stenting or carotid endarterectomy.

13 unger patients and in those not suitable for endarterectomy.

14 ients with carotid artery disease undergoing endarterectomy.

15 and absence of previous ipsilateral carotid endarterectomy.

16 r carotid artery stenting than after carotid endarterectomy.

17 iomarker+ only were more common with carotid endarterectomy.

18 owever, many cases can be cured by pulmonary endarterectomy.

19 stochemistry for patients undergoing carotid endarterectomy.

20 ssed over from ACP to DHCA to allow complete endarterectomy.

21 coronary-artery bypass grafting and carotid endarterectomy.

22 of myocardial infarction (MI) after carotid endarterectomy.

23 o receive carotid artery stenting or carotid endarterectomy.

24 carotid artery stenting with that of carotid endarterectomy.

25 d improve the risk-benefit ratio for carotid endarterectomy.

26 ry stenting and the group undergoing carotid endarterectomy.

27 o undergo carotid-artery stenting or carotid endarterectomy.

28 acy of carotid artery stenting compared with endarterectomy.

29 otid stenosis who are likely to benefit from endarterectomy.

30 a higher risk of myocardial infarction with endarterectomy.

31 obtained from patients who underwent carotid endarterectomy.

32 ary artery bypass graft surgery, and carotid endarterectomy.

33 arotid artery stenting compared with carotid endarterectomy.

34 thin the previous 5 days) undergoing carotid endarterectomy.

35 ma during the first 72 hours after pulmonary endarterectomy.

36 r measurements were obtained after pulmonary endarterectomy.

37 scular lung water variations after pulmonary endarterectomy.

38 istics and outcome in men undergoing carotid endarterectomy.

39 ed 1 hour, 1 day, and 2 days after pulmonary endarterectomy.

40 receiving carotid stenting and 43 receiving endarterectomy.

41 ng from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2% in 2008)

42 decrease from 1999 to 2014 was observed for endarterectomy (1.4%; 95% CI, 1.2% to 1.5%) but not sten

43 ed with 16 (3.8%) of 417 assigned to carotid endarterectomy (1.84, 1.01-3.37; interaction p=0.064).

44 n increased rate of restenosis after carotid endarterectomy (2.26, 1.34-3.77) but not after carotid a

45 plan-Meier rate 6.0%) and 62 who had carotid endarterectomy (6.3%) had restenosis or occlusion (hazar

46 procedures were herniorrhaphy (10%), carotid endarterectomy (6.6%), and open colectomy (5.6%).

47 Of 366 patients with carotid endarterectomy, 61 exhibited some degree of LOY in blood

48 R and VSF-trained surgeons following carotid endarterectomy (8%-IVSR vs. 7%-VSF), lower extremity rev

49 troke or death in patients receiving carotid endarterectomy, a harm of screening included the risk fo

50 signed to carotid artery stenting or carotid endarterectomy (Abbott Vascular).

51 s for 1-year ischemic stroke decreased after endarterectomy (absolute decrease, 3.5% [95% CI, 3.2% to

52 By comparing endovascular treatment with endarterectomy after the 30-day post-treatment period, t

53 Before carotid endarterectomy, all patients underwent positron emission

54 h-grade stenosis derive benefit from carotid endarterectomy, although they have different risk profil

55 ith gene expression profiling of 121 carotid endarterectomies and an analysis of protein secretion by

56 2.63% to 3.18%) among patients who underwent endarterectomy and 1.13% (95% CI, 0.71% to 1.54%) among

57 th culprit carotid stenosis awaiting carotid endarterectomy and 8 controls without culprit carotid at

58 Carotid endarterectomy and carotid artery stenting are the leadi

59 burden in women, review outcomes of carotid endarterectomy and carotid artery stenting in women, dis

60 gement include antiplatelet therapy, carotid endarterectomy and carotid artery stenting.

61 tes were similar up to 2 years after carotid endarterectomy and carotid artery stenting.

62 Carotid endarterectomy and carotid artery stenting.

63 eased between the first hour after pulmonary endarterectomy and day 2 (10.2 +/- 2.6 vs 11.4 +/- 3.6;

64 Vascular atheroma excised at endarterectomy and endomyocardial biopsies contained pur

65 from 67% to 81% among patients who underwent endarterectomy and from 61% to 70% among patients who un

66 reperfusion pulmonary edema after pulmonary endarterectomy and had prognostic value.

67 s well below the risk of carotid stenting or endarterectomy and has decreased markedly with more inte

68 mmon after endovascular treatment than after endarterectomy and is associated with recurrent ipsilate

69 Human plaques were derived from carotid endarterectomy and stained against P2X7.

70 rends in performance and outcomes of carotid endarterectomy and stenting among Medicare beneficiaries

71 ncluded immediate revascularization (carotid endarterectomy) and ongoing medical therapy (with antipl

72 en abdominal aortic aneurysm repair, carotid endarterectomies, and peripheral vascular operations com

73 pheral arterial disease include angioplasty, endarterectomy, and bypass grafting.

74 It can be cured by pulmonary endarterectomy, and can be clinically improved by medica

75 se are optimizing medical treatment, carotid endarterectomy, and carotid artery stenting.

76 oke to target interventions, such as carotid endarterectomy, anticoagulation for atrial fibrillation,

77 g, abdominal aortic aneurysm repair, carotid endarterectomy, aortic valve replacement, esophagectomy,

78 Carotid-artery stenting and carotid endarterectomy are both options for treating carotid-art

79 es such as iliac stenting and common femoral endarterectomy are commonly used to reduce operative ris

80 ge, and at standard or high risk for carotid endarterectomy are eligible for enrollment.

81 the endovascular arm than in patients in the endarterectomy arm (adjusted hazard ratio [HR] 3.17, 95%

82 .7% in the endovascular arm and 10.5% in the endarterectomy arm.

83 time interval between ischaemic symptoms and endarterectomy as the clearest risk factor for CHS.

84 igned 1:1 to open treatment with stenting or endarterectomy at 50 centres worldwide.

85 al perfusion defects should be evaluated for endarterectomy, balloon pulmonary angioplasty, or vasodi

86 he NCDR Carotid Artery Revascularization and Endarterectomy (CARE) Registry were included.

87 id artery stenting (CAS) relative to carotid endarterectomy (CEA) among Medicare patients has not bee

88 he risk of stroke or death following carotid endarterectomy (CEA) and carotid artery stenting (CAS) o

89 dmission between patients undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS);

90 atients with carotid artery disease, carotid endarterectomy (CEA) and carotid stenting (CAS) are trea

91 al ischemic DWI lesions after CAS or carotid endarterectomy (CEA) are associated with an increased ri

92 er carotid artery stenting (CAS) and carotid endarterectomy (CEA) are lacking.

93 s excluding dialysis patients showed carotid endarterectomy (CEA) decreased stroke risk compared with

94 Staged carotid endarterectomy (CEA) followed by OHS or combined CEA and

95 roke is a persistent complication of carotid endarterectomy (CEA) for patients with symptomatic carot

96 tid artery stenting (CAS) and carotid artery endarterectomy (CEA) for the prevention of stroke due to

97 r carotid artery stenting (CAS) than carotid endarterectomy (CEA) for the treatment of symptomatic ca

98 tomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and stenting

99 en the controversy regarding whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) ma

100 sk of major adverse events following carotid endarterectomy (CEA) or carotid artery stenting (CAS), t

101 sed as determinants of outcome after carotid endarterectomy (CEA) or carotid artery stenting (CAS).

102 articles comparing early outcomes of carotid endarterectomy (CEA) or carotid stenting (CAS) in elderl

103 Carotid revascularization with carotid endarterectomy (CEA) or stenting (CAS) is frequently per

104 The benefit of carotid endarterectomy (CEA) over medical therapy in patients wi

105 e alternative for high-risk surgical carotid endarterectomy (CEA) patients.

106 nal aortic aneurysm repair (OAR) and carotid endarterectomy (CEA) performed by very low-volume surgeo

107 ve studies of medical therapy alone, carotid endarterectomy (CEA) plus medical therapy, or carotid ar

108 r neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence for some y

109 It is generally accepted that carotid endarterectomy (CEA) reduces the risk of stroke in sympt

110 be administered at the conclusion of carotid endarterectomy (CEA) to reverse the anticoagulant effect

111 strated that CAS was not inferior to carotid endarterectomy (CEA) when performed by physicians experi

112 has achieved clinical equipoise with carotid endarterectomy (CEA), as evidenced by 2 large U.S. rando

113 reatment than it was in patients assigned to endarterectomy (CEA), raising concerns about the long-te

114 ng carotid artery stenting (CAS) and carotid endarterectomy (CEA), with better CEA outcomes than CAS

115 CHS) is an important complication of carotid endarterectomy (CEA), yet prior research has been limite

116 nts with carotid artery stenosis for carotid endarterectomy (CEA).

117 carotid artery stenting (CAS) versus carotid endarterectomy (CEA).

118 At present, carotid endarterectomy combined with optimal drug therapy remain

119 sks of stroke and complications from carotid endarterectomy, costs, and quality of life values were e

120 re beneficiaries, the performance of carotid endarterectomy declined from 1999 to 2014, whereas the p

121 g surgery (lung transplantation or pulmonary endarterectomy) during 6 months.

122 nt elective major vascular surgery - carotid endarterectomy, EVAR, open AAA repair, bypass for lower

123 thout stenting) is an alternative to carotid endarterectomy for carotid artery stenosis but there are

124 dema is a specific complication of pulmonary endarterectomy for chronic thromboembolic pulmonary hype

125 the intervention in the 3 trials was carotid endarterectomy for patients with stenosis exceeding 50%

126 gulation for atrial fibrillation and carotid endarterectomy for severe symptomatic carotid artery ste

127 k of stroke or death associated with carotid endarterectomy for symptomatic carotid stenosis decrease

128 ents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but pre

129 isabling stroke are similar for stenting and endarterectomy for symptomatic carotid stenosis.

130 between carotid artery stenting and carotid endarterectomy for symptomatic or asymptomatic carotid s

131 Stenting is an endovascular alternative to endarterectomy for the management of carotid stenosis, b

132 tic carotid arteries were examined following endarterectomy for the presence of the Gram-positive bac

133 Stenting is an alternative to endarterectomy for treatment of carotid artery stenosis,

134 R) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, tr

135 e frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population,

136 y severity in the stenting group than in the endarterectomy group (31 vs 50 events; p=0.0197).

137 end point between the stenting group and the endarterectomy group (7.2% and 6.8%, respectively; hazar

138 the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2.4

139 nfidence interval [CI], 9.1 to 14.8) and the endarterectomy group (9.9%; 95% CI, 7.9 to 12.2) over 10

140 group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.7

141 s 2.9% in the stenting group and 1.7% in the endarterectomy group (P=0.33).

142 93.1% in the stenting group and 94.7% in the endarterectomy group (P=0.44).

143 97.8% in the stenting group and 97.3% in the endarterectomy group (P=0.51), and the overall survival

144 fect was driven by a decrease in the carotid endarterectomy group (unadjusted odds ratio per year, 0.

145 more cranial nerve palsies (22 vs 0) in the endarterectomy group than in the endovascular group.

146 which 11 in the stenting group and 9 in the endarterectomy group were ipsilateral.

147 ifference between the stenting group and the endarterectomy group with respect to the primary composi

148 atients in the stenting group and one in the endarterectomy group withdrew immediately after randomis

149 rolled 1713 patients (stenting group, n=855; endarterectomy group, n=858).

150 ere higher in the stenting group than in the endarterectomy group.

151 l, compared with four, all non-fatal, in the endarterectomy group.

152 n the stenting group compared with 45 in the endarterectomy group.

153 differed between the stenting group and the endarterectomy group: for death (0.7% vs. 0.3%, P=0.18),

154 in 5.6% (95% CI, 3.7 to 7.6) of those in the endarterectomy group; the rates did not differ significa

155 iffer significantly between the stenting and endarterectomy groups (6.4% vs 6.5%; hazard ratio [HR] 1

156 d to carotid artery stenting, 500 to carotid endarterectomy) had baseline imaging available.

157 endovascular treatment and 213 patients had endarterectomy) had prospective clinical follow-up at a

158 arotid artery stenting and 28 MIs in carotid endarterectomy (hazard ratio, 0.50; 95% confidence inter

159 r death was 6.4% with stenting and 4.7% with endarterectomy (hazard ratio, 1.50; P=0.03); the rates a

160 ality were smoking history, previous carotid endarterectomy, hemoglobin level, and increasing age.

161 ed with 40 (4.9%) of 823 assigned to carotid endarterectomy (HR 0.90, 95% CI 0.57-1.41) and 31 (6.8%)

162 association in patients treated with carotid endarterectomy (HR for any stroke 1.18, 0.40-3.55; p=0.7

163 There were 81306 patients who underwent endarterectomy in 1999 and 36325 in 2014; national rates

164 an emboli-protection device as compared with endarterectomy in 334 patients at increased risk for com

165 on MR images would undergo immediate carotid endarterectomy in addition to ongoing intensive medical

166 ial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Stand

167 The effect of carotid endarterectomy in lowering the risk of stroke ipsilatera

168 stenting with embolic protection and carotid endarterectomy in patients 79 years of age or younger wh

169 ion") is an effective alternative to carotid endarterectomy in patients at average or high risk for s

170 higher risk of stroke compared with carotid endarterectomy in patients with an ARWMC score of 7 or m

171 h >/=50 patients that compared stenting with endarterectomy in patients with carotid stenosis.

172 ight be an acceptable alternative to carotid endarterectomy in patients with less extensive lesions.

173 between carotid artery stenting and carotid endarterectomy in patients with symptomatic and asymptom

174 lve the role of carotid stenting and carotid endarterectomy in primary and secondary stroke preventio

175 aques of patients undergoing primary carotid endarterectomy in the province of Utrecht from 2002 to 2

176 ven to be a potential alternative to carotid endarterectomy in the treatment of severe carotid diseas

177 Pulmonary endarterectomy is a successful treatment of chronic thro

178 Carotid endarterectomy is associated with similar neurologic out

179 W measured at the first hour after pulmonary endarterectomy is closely associated with reperfusion pu

180 When pulmonary endarterectomy is not an option, pulmonary arterial hype

181 c pulmonary hypertension, surgical pulmonary endarterectomy is the treatment of choice.

182 with Protection in Patients at High Risk for Endarterectomy), looked at 1-year stroke, death, and MI

183 dy, 937111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women) and 231

184 s in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic carotid

185 clerotic lesions using Biobank of Karolinska Endarterectomies microarray data.

186 2 patients were randomly assigned to carotid endarterectomy (n=1240) or carotid artery stenting (n=12

187 carotid artery stenting (n=2326) or carotid endarterectomy (n=2271) in 4 randomized trials between 2

188 atients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4

189 egistry-Carotid Artery Revascularization and Endarterectomy (NCDR CARE) Registry, we compared patient

190 cal therapy-only group could undergo carotid endarterectomy only with substantial carotid artery sten

191 Carotid revascularization with endarterectomy or angioplasty and stenting are establish

192 n, lower-extremity arterial disease, carotid endarterectomy or angioplasty, or abdominal aortic aneur

193 the odds of procedural intervention (carotid endarterectomy or carotid artery stenting) compared with

194 s deemed equally suitable for either carotid endarterectomy or endovascular treatment were randomly a

195 Revascularization with endarterectomy or stenting can benefit select patients.

196 tice, decision making with regard to carotid endarterectomy or stenting is still primarily based on t

197 ials demonstrated the superiority of carotid endarterectomy over medical therapy in the prevention of

198 = 0.03); the effect was greatest in carotid endarterectomy patients (RB = 73.4% vs. no RB = 67.7%, P

199 When compared with carotid stenting, endarterectomy patients demonstrated postoperative impro

200 Carotid endarterectomy patients had a lower procedural stroke or

201 nal 8 carotid artery stenting and 12 carotid endarterectomy patients had biomarker+ only (hazard rati

202 To evaluate surgical success after pulmonary endarterectomy (PEA) by means of cardiopulmonary magneti

203 Pulmonary endarterectomy (PEA) is potentially curative, but residu

204 Pulmonary endarterectomy (PEA) is the gold standard treatment for

205 rrent pulmonary hypertension after pulmonary endarterectomy (PEA) who were receiving the soluble guan

206 lmonary hypertension (CTEPH) after pulmonary endarterectomy (PEA).

207 female with a history of stroke and carotid endarterectomy presented with 3 weeks of vaginal bleedin

208 Carotid endarterectomy presents a risk of myocardial infarction

209 In a meta-analysis, carotid endarterectomy reduced rates of 1) perioperative stroke,

210 (NCDR) Carotid Artery Revascularization and Endarterectomy Registry (2006-2008/2009).

211 nd 4055 Carotid Artery Revascularization and Endarterectomy Registry (2824 CAS; 1231 CEA) Medicare pa

212 44.5%; Carotid Artery Revascularization and Endarterectomy Registry: 71.3% versus 44.7%).

213 ) CARE (Carotid Artery Revascularization and Endarterectomy) Registry for carotid revascularization;

214 ts long-term safety and efficacy relative to endarterectomy remain unclear.

215 ughout follow-up with stenting suggests that endarterectomy remains the treatment of choice for carot

216 Surgical pulmonary endarterectomy remains the treatment of choice for CTEPH

217 ing coronary artery bypass grafting, carotid endarterectomy, repair of nonruptured abdominal aortic a

218 atients with de novo atherosclerotic or post-endarterectomy restenotic lesions in native carotid arte

219 comparing filter-protected CAS with carotid endarterectomy revealed a higher periprocedural stroke r

220 ssion in >70 samples obtained during carotid endarterectomy revealed that local miR-100 expression wa

221 ell RNA sequencing of advanced human carotid endarterectomy samples and compared these with single-ce

222 pertoires were analyzed by RT-PCR in carotid endarterectomy samples.

223 ability as seen in humans, and human carotid endarterectomy samples.

224 With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) trial or Carotid Revasculariza

225 In the meantime, carotid endarterectomy should remain the treatment of choice for

226 rosclerotic plaques harvested during carotid endarterectomy show a time-dependent change in plaque co

227 mong vascular patients scheduled for carotid endarterectomy significantly improved over the past deca

228 endothelial cells, murine venous thrombi, or endarterectomy specimens and plasma of CTEPH patients, a

229 crophage content was assessed in all carotid endarterectomy specimens as a percentage of CD68(+)-stai

230 Carotid endarterectomy specimens from 16 patients who were sched

231 ix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic versus 6 asy

232 Pulmonary endarterectomy specimens from CTEPH patients were analyz

233 ptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic

234 Carotid endarterectomy specimens of 20 patients were incubated w

235 In human carotid endarterectomy specimens TLR7 levels were consistently a

236 We further incubated human atherosclerotic endarterectomy specimens with clinically relevant concen

237 d by immunohistochemical staining of carotid endarterectomy specimens.

238 bsets in cultures derived from human carotid endarterectomy specimens.

239 1 binds to MIF in plaques from human carotid-endarterectomy specimens.

240 21, P=0.019) in the 10 corresponding carotid endarterectomy specimens.

241 When compared with endarterectomy, stenting was associated with an increase

242 tients aged 18-80 years undergoing pulmonary endarterectomy surgery in a UK centre (Papworth Hospital

243 risk of surgical complications or even avert endarterectomy surgery in some cases.

244 In human plaques, collected during carotid endarterectomy surgery, we found that 14q32 microRNA (mi

245 m modality for patients undergoing pulmonary endarterectomy surgery.

246 candidate for potentially curative pulmonary endarterectomy surgery.

247 event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevation of ser

248 restenosis after endovascular treatment and endarterectomy, the effect of the use of stents on reste

249 ired from on-going trials of stenting versus endarterectomy to ascertain whether long-term ultrasound

250 rrent pulmonary hypertension after pulmonary endarterectomy to receive placebo or riociguat.

251 lesions in carotid arteries require surgical endarterectomy to reduce the risk of ischemic stroke.

252 ed by the North American Symptomatic Carotid Endarterectomy Trial (NASCET).

253 ous Angioplasty of the Carotid Artery versus Endarterectomy trial, International Carotid Stenting Stu

254 , NASCET [North American Symptomatic Carotid Endarterectomy Trial] <70%).

255 th Protection of Patients with High Risk for Endarterectomy) trial demonstrated that CAS was not infe

256 are needed from the on going stenting versus endarterectomy trials.

257 Twenty patients scheduled for carotid endarterectomy underwent 3.0-T carotid MR imaging, inclu

258 Thirty-four patients undergoing carotid endarterectomy underwent screening of carotid atheroscle

259 r treatment of symptomatic carotid stenosis (Endarterectomy versus Angioplasty in Patients with Sympt

260 In patients randomized to carotid endarterectomy versus carotid artery stenting, both MI a

261 he CREST protocol (Carotid Revascularization Endarterectomy Versus Stent Trial).

262 vidence from randomized controlled trials of endarterectomy versus stenting shows a higher rate of st

263 The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) found a hig

264 While the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) has been wi

265 In the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the compos

266 In the randomised Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the primar

267 ve occurred in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).

268 (Carotid Revascularization Endarterectomy versus Stenting Trial [CREST]; NCT0000473

269 isk of CEA, CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) found no differenc

270 In CREST (Carotid Revascularization Endarterectomy versus Stenting Trial), the largest rando

271 tenting Study, and Carotid Revascularization Endarterectomy versus Stenting Trial).

272 In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found no signif

273 SAPPHIRE) trial or Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) enrollment crit

274 Pulmonary endarterectomy was performed with a 4.7% documented mort

275 aterial from the BiKE (Biobank of Karolinska Endarterectomies), we profiled miRNA expression in patie

276 aterial from the BiKE (Biobank of Karolinska Endarterectomies), we profiled miRNA expression in patie

277 ho had been randomly assigned to stenting or endarterectomy, we evaluated outcomes every 6 months for

278 METHODS AND Carotid endarterectomies were obtained from patients with sympto

279 aparoscopic cholecystectomies and 22 carotid endarterectomies were studied using direct observation m

280 arotid artery stenting compared with carotid endarterectomy were 6.2% versus 6.8% in men (hazard rati

281 were hemodynamically stable after pulmonary endarterectomy were divided into two groups based on whe

282 derwent CT angiography and were referred for endarterectomy were enrolled.

283 id artery stenosis and who underwent carotid endarterectomy were included in the study.

284 age +/- SD, 68.3 +/- 7.3) undergoing carotid endarterectomy were recruited for combined carotid (18)F

285 of ipsilateral stroke with stenting and with endarterectomy were similarly low (2.0% and 2.4%, respec

286 Human atherosclerotic plaques obtained by endarterectomy were staged and analyzed for C5L2 and C5a

287 stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

288 stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

289 id artery stenting (CAS) relative to carotid endarterectomy when performed by physicians with demonst

290 artery stenting than those who have carotid endarterectomy whereas there is little difference in men

291 esent after surgery, most commonly following endarterectomy, which is a rare cause with an estimated

292 artery stenting (CAS) compared with carotid endarterectomy, which may differ in specific patient sub

293 nts at increased risk for complications from endarterectomy who had either a symptomatic carotid arte

294 the randomized trial data comparing carotid endarterectomy with carotid artery stenting and describe

295 Stenting was noninferior to endarterectomy with regard to the primary composite end

296 l complications, stenting was noninferior to endarterectomy with regard to the rate of the primary co

297 o underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedura

298 ubjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Ste

299 afety and efficacy of stenting with those of endarterectomy, with a particular focus on long-term out

300 Carotid endarterectomy without another concurrent surgery.